BioCentury
ARTICLE | Clinical News

Tigecycline regulatory update

November 11, 2013 8:00 AM UTC

Stem Cell Therapeutics said FDA granted Orphan Drug designation to tigecycline to treat acute myelogenous leukemia (AML). The glycylcycline antibiotic is in a Phase I trial in patients with relapsed o...